CredoWeb VIDEO interview with Prof Javed Butler, The University of Mississippi Medical Center, Jackson, US

• Why polypharmacy in treating heart failure is not a problem but a progress? The real problem now is polymorbidity, not polypharmacy, explains Prof Javed Butler.  Polypharmacy is when a patient takes 2 or 3 drugs to control a chronic disease. But polypharmacy side effects are manageable and in reality polypharmacy is a blessing that we actually have therapies for patients.
• What is the good news in treatment of patients with heart failure? There is a lot of progress in this area but the latest buzz is that group of medications called SGLT2 inhibitors.  They work both for heart failure and diabetes - one drug, one dose, once a day.
• The modern quadriple therapy for HF – why so limited patients in the world are on this therapy? Number 1 issue both with doctors and patients is: the disease has to be treated irrespective of whether a patient has little symptoms or too many symptoms.
• Bio ... ...
...